HomeORCHPHARMA • NSE
add
Orchid Pharma Ltd
Previous close
₹1,676.15
Day range
₹1,631.65 - ₹1,692.00
Year range
₹702.75 - ₹1,997.40
Market cap
83.43B INR
Avg Volume
67.08K
P/E ratio
68.67
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.23B | 12.05% |
Operating expense | 698.25M | 14.56% |
Net income | 272.36M | 37.53% |
Net profit margin | 12.23 | 22.79% |
Earnings per share | 5.37 | — |
EBITDA | 302.47M | 30.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.44B | 384.25% |
Total assets | 16.35B | 9.59% |
Total liabilities | 4.11B | 6.94% |
Total equity | 12.24B | — |
Shares outstanding | 50.72M | — |
Price to book | 6.94 | — |
Return on assets | — | — |
Return on capital | 4.03% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 272.36M | 37.53% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Founded
1992
Website
Employees
871
